| Phase 4 |
| NCT05043870 |
Combined Immunosuppression for Pediatric Crohn's Disease |
Crohn Disease |
Recruiting |
| NCT07550673 |
Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative… |
Acute Severe Ulcerative Colitis |
Recruiting |
| NCT05823532 |
Anti-Inflammatory Challenge in Schizophrenia |
Schizophrenia |
Recruiting |
| NCT07415473 |
Akkermansia Muciniphila Combined With Infliximab for Promoting Intestinal Mucosal Healing… |
Crohn's Diseases |
Not Yet Recruiting |
| NCT07417696 |
Palmitoleic Acid Combined With Infliximab for Promoting Intestinal Mucosal Healing in… |
Crohn's Disease |
Not Yet Recruiting |
| NCT04835506 |
Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of… |
Crohn Disease |
Active, Not Recruiting |
| NCT07352566 |
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis |
Psoriasis |
Not Yet Recruiting |
| Phase 3 |
| NCT06647953 |
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary… |
Pleuropulmonary Blastoma |
Recruiting |
| NCT04043494 |
International Cooperative Treatment Protocol for Children and Adolescents With… |
Lymphoblastic Lymphoma, Childhood |
Recruiting |
| NCT03206671 |
Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell… |
Mature B-cell Non-Hodgkin Lymphoma |
Active, Not Recruiting |
| NCT03007147 |
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed… |
Acute Lymphoblastic Leukemia |
Active, Not Recruiting |
| NCT06230224 |
A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for… |
B-Cell Non-Hodgkin Lymphoma (B-NHL) |
Active, Not Recruiting |
| NCT02112916 |
Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With… |
Adult T Acute Lymphoblastic Leukemia |
Active, Not Recruiting |
| NCT02306161 |
Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly… |
Metastatic Ewing Sarcoma |
Active, Not Recruiting |
| NCT03596645 |
A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With… |
Colitis, Ulcerative |
Active, Not Recruiting |
| Phase 2/3 |
| NCT05991388 |
A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory… |
B-cell Non Hodgkin Lymphoma |
Recruiting |
| NCT05660746 |
Precise Infliximab Exposure and Pharmacodynamic Control |
Crohn Disease |
Recruiting |
| NCT06820957 |
Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing… |
CIC-Rearranged Sarcoma |
Active, Not Recruiting |
| NCT02180867 |
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in… |
Alveolar Soft Part Sarcoma |
Active, Not Recruiting |
| Phase 2 |
| NCT06835049 |
Feasibility of Total Neoadjuvant Treatment With HYPErthermia in Patients With High-risk… |
Sarcoma,Soft Tissue |
Recruiting |
| NCT06941376 |
An Open-Label Study of Effectiveness of Immunomodulatory Medications for Patients With… |
Relapsing Polychondritis |
Recruiting |
| NCT06528496 |
N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in… |
High-risk Neuroblastoma |
Recruiting |
| NCT07477457 |
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard… |
Osteosarcoma |
Recruiting |
| NCT03418038 |
Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma… |
Clonal Cytopenia of Undetermined Significance |
Recruiting |
| NCT04322318 |
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed… |
Anaplastic Kidney Wilms Tumor |
Recruiting |